Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel

Vandetanib (ZD6474, Zactima™) is a novel, orally available inhibitor of different intracellular signaling pathways involved in tumor growth, progression, and angiogenesis, including vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and rearranged during transfection ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Young-Min, Roh, Joo-Young, Cho, Eun-Kyung, Lee, Jong-Rok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276785/
https://www.ncbi.nlm.nih.gov/pubmed/22346266
http://dx.doi.org/10.5021/ad.2011.23.S3.S314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276785/
https://www.ncbi.nlm.nih.gov/pubmed/22346266
http://dx.doi.org/10.5021/ad.2011.23.S3.S314

Ejemplares similares